An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells

Abstract The combination therapy which has been proposed as the strategy for the cancer treatment could achieve a synergistic effect for cancer therapies and reduce the dosage of the applied drugs. On account of the the unique properties as the high absorbed water content, biocompatibility, and flex...

Full description

Bibliographic Details
Main Authors: Fatemeh Abedi, Soodabeh Davaran, Malak Hekmati, Abolfazl Akbarzadeh, Behzad Baradaran, Sevil Vaghefi Moghaddam
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-020-00764-6
_version_ 1828365012015513600
author Fatemeh Abedi
Soodabeh Davaran
Malak Hekmati
Abolfazl Akbarzadeh
Behzad Baradaran
Sevil Vaghefi Moghaddam
author_facet Fatemeh Abedi
Soodabeh Davaran
Malak Hekmati
Abolfazl Akbarzadeh
Behzad Baradaran
Sevil Vaghefi Moghaddam
author_sort Fatemeh Abedi
collection DOAJ
description Abstract The combination therapy which has been proposed as the strategy for the cancer treatment could achieve a synergistic effect for cancer therapies and reduce the dosage of the applied drugs. On account of the the unique properties as the high absorbed water content, biocompatibility, and flexibility, the targeting nanogels have been considred as a suitable platform. Herein, a non-toxic pH/thermo-responsive hydrogel P(NIPAAm-co-DMAEMA) was synthesized and characterized through the free-radical polymerization and expanded upon an easy process for the preparation of the smart responsive nanogels; that is, the nanogels were used for the efficient and controlled delivery of the anti-cancer drug doxorubicin (DOX) and chemosensitizer curcumin (CUR) simultaneously like a promising strategy for the cancer treatment. The size of the nanogels, which were made, was about 70 nm which is relatively optimal for the enhanced permeability and retention (EPR) effects. The DOX and CUR co-loaded nanocarriers were prepared by the high encapsulation efficiency (EE). It is important to mention that the controlled drug release behavior of the nanocarriers was also investigated. An enhanced ability of DOX and CUR-loaded nanoformulation to induce the cell apoptosis in the HT-29 colon cancer cells which represented the greater antitumor efficacy than the single-drug formulations or free drugs was resulted through the In vitro cytotoxicity. Overall, according to the data, the simultaneous delivery of the dual drugs through the fabricated nanogels could synergistically potentiate the antitumor effects on the colon cancer (CC).
first_indexed 2024-04-14T05:25:00Z
format Article
id doaj.art-0e92a22d19034531828664e8b83725a1
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-14T05:25:00Z
publishDate 2021-01-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-0e92a22d19034531828664e8b83725a12022-12-22T02:10:01ZengBMCJournal of Nanobiotechnology1477-31552021-01-0119112210.1186/s12951-020-00764-6An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cellsFatemeh Abedi0Soodabeh Davaran1Malak Hekmati2Abolfazl Akbarzadeh3Behzad Baradaran4Sevil Vaghefi Moghaddam5Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad UniversityDrug Applied Research Center, Tabriz University of Medical SciencesDepartment of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad UniversityDepartment of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical SciencesImmunology Research Center, Tabriz University of Medical SciencesDrug Applied Research Center, Tabriz University of Medical SciencesAbstract The combination therapy which has been proposed as the strategy for the cancer treatment could achieve a synergistic effect for cancer therapies and reduce the dosage of the applied drugs. On account of the the unique properties as the high absorbed water content, biocompatibility, and flexibility, the targeting nanogels have been considred as a suitable platform. Herein, a non-toxic pH/thermo-responsive hydrogel P(NIPAAm-co-DMAEMA) was synthesized and characterized through the free-radical polymerization and expanded upon an easy process for the preparation of the smart responsive nanogels; that is, the nanogels were used for the efficient and controlled delivery of the anti-cancer drug doxorubicin (DOX) and chemosensitizer curcumin (CUR) simultaneously like a promising strategy for the cancer treatment. The size of the nanogels, which were made, was about 70 nm which is relatively optimal for the enhanced permeability and retention (EPR) effects. The DOX and CUR co-loaded nanocarriers were prepared by the high encapsulation efficiency (EE). It is important to mention that the controlled drug release behavior of the nanocarriers was also investigated. An enhanced ability of DOX and CUR-loaded nanoformulation to induce the cell apoptosis in the HT-29 colon cancer cells which represented the greater antitumor efficacy than the single-drug formulations or free drugs was resulted through the In vitro cytotoxicity. Overall, according to the data, the simultaneous delivery of the dual drugs through the fabricated nanogels could synergistically potentiate the antitumor effects on the colon cancer (CC).https://doi.org/10.1186/s12951-020-00764-6pH/thermo-responsiveNanogelsDual-drug deliveryControlled releaseCombination therapy
spellingShingle Fatemeh Abedi
Soodabeh Davaran
Malak Hekmati
Abolfazl Akbarzadeh
Behzad Baradaran
Sevil Vaghefi Moghaddam
An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
Journal of Nanobiotechnology
pH/thermo-responsive
Nanogels
Dual-drug delivery
Controlled release
Combination therapy
title An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
title_full An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
title_fullStr An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
title_full_unstemmed An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
title_short An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
title_sort improved method in fabrication of smart dual responsive nanogels for controlled release of doxorubicin and curcumin in ht 29 colon cancer cells
topic pH/thermo-responsive
Nanogels
Dual-drug delivery
Controlled release
Combination therapy
url https://doi.org/10.1186/s12951-020-00764-6
work_keys_str_mv AT fatemehabedi animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT soodabehdavaran animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT malakhekmati animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT abolfazlakbarzadeh animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT behzadbaradaran animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT sevilvaghefimoghaddam animprovedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT fatemehabedi improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT soodabehdavaran improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT malakhekmati improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT abolfazlakbarzadeh improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT behzadbaradaran improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells
AT sevilvaghefimoghaddam improvedmethodinfabricationofsmartdualresponsivenanogelsforcontrolledreleaseofdoxorubicinandcurcumininht29coloncancercells